Novartis Investigative Site

Sao Jose Rio Preto 15090 000

0 studies enrolling now · 4 studies all time

What they study most

Autoimmunity, Inflammation, IgA Nephropathy, Metastatic Breast Cancer, Primary IgA Nephropathy

Studies at this site

• Secukinumab Open Label Roll-over Extension Protocol — Recruiting now
• A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy — Running, not enrolling
• Roll-over Study to Allow Continued Access to Ribociclib — Running, not enrolling
• Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients — Completed